Abstract
Polymeric micelle or self-aggregate formations have received much attention as carriers for drug delivery systems because of their high efficiency for drug delivery. Our recent results in the formation of nano-aggregates using chemically modified chitosan encouraged us to investigate the possibility of applying them as drug carriers. Therefore, we investigated a novel chitosan-based nano-aggregate as a drug carrier for sustained protein release. Thermosensitive chitosan–Pluronic (CP) was prepared by grafting monocarboxy Pluronic F127 onto the chitosan using 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide and N-hydroxysuccinimide. Bovine serum albumin (BSA)-loaded CP nano-aggregate was prepared by the direct dissolution method based on thermosensitive property of the CP copolymer. The physico–chemical properties of CP nano-aggregates were characterised by critical aggregate concentration, dynamic light scattering, and ζ-potential. In vitro release studies were investigated with BSA as a model protein at 37°C. BSA released from the CP nano-aggregates for about 6 h. The results suggest that CP nano-aggregates can potentially be efficient nanocarriers for protein delivery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
